Mitarbeiter
Dr. Mostafa Samak
Versuchstierkunde
+49 551 3851-125
B1.13
Kellnerweg 4
37077 Göttingen
-
Gestörte Mikrozirkulation bei Diabetes mellitus
-
Diabetische Kardiomyopathie
-
Endothelbiologie
Ausbildung
-
Promotion - Molekulare Medizin (Dr. rer. nat.) - Georg-August Universität Göttingen
-
Masterstudium - Molekulare Medizin - Georg-August Universität Göttingen
-
Bachelorstudium - Pharmazeutische Wissenschaften - Ägypten
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Deutsche Gesellschaft für Kardiologie (DGK)
- European Vascular Biology Organization (EVBO)
-
Samak M et al.: Dysregulation of Krüppel-like factor 2 and myocyte enhancer factor 2D drive cardiac microvascular inflammation in diabetes. Int J Mol Sci. 2023; 24(3):2482. doi: 10.3390/ijms24032482.
-
Samak M et al.: Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes. Biomedicines, 2022; 10(1):58. doi: 10.3390/biomedicines10010058.
-
Samak M and Hinkel R: Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. Cells; 8(12):1530. doi: 10.3390/cells8121530.
-
Samak M et al.: Total Arterial Revascularization: Bypassing Antiquated Notions to Better Alternatives for Coronary Artery Disease. Med Sci Monit Basic Res, 2016; 22:107-114. doi: 10.12659/msmbr.901508.
-
Samak M et al.: Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis. Med Sci Monit Basic Res, 2016 Jul 23; 22:75-79. doi: 10.12659/MSMBR.900437.
-
Samak M et al.: Past and Present of Total Artificial Heart Therapy: A Success Story. Med Sci Monit Basic Res, 2015 Sep 7; 21:183-90. doi: 10.12659/MSMBR.895418.
-
Fatullayev J*, Samak M* et al.: Non-Heart Beating Donor Heart Transplantation: Breaking the Taboo. Med Sci Monit Basic Res, 2015 Jul 15; 21:153-6. doi: 10.12659/MSMBR.894985. *Equal contribution
-
Fatullayev J, Samak M et al.: Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Forseen is a Danger Avoided. Med Sci Monit Basic Res, 2015 Jul 1; 21:141-144. doi: 10.12659/MSMBR.894840.
Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes.
Download (8 MB)